Gain Therapeutics, Inc. (GANX) — Analyst estimates
Consensus analyst estimates for Gain Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 33.33K | -0.14 | 1 |
| 2027 | 0 | -0.23 | 1 |
| 2028 | 100.29M | -0.76 | 2 |
| 2029 | 48.07M | -0.02 | 1 |
| 2030 | 134.57M | 1.64 | 1 |
Consensus analyst estimates by fiscal year.